Clinical trial
Trial in Subjects Undergoing Cardiac Catheterization With Planned Percutaneous…
NCT00357968 · Eli Lilly and Company, Industry · Completed
Key facts
| NCT number | NCT00357968 |
|---|---|
| Title | Trial in Subjects Undergoing Cardiac Catheterization With Planned Percutaneous Coronary Intervention With Stenting |
| Official title | Protocol H7T-MC-TABL(a) PRasugrel IN Comparison to Clopidogrel for Inhibition of PLatelet Activation and AggrEgation (PRINCIPLE) - TIMI 44 |
| Acronym | PRINCIPLE |
| Lead sponsor | Eli Lilly and Company, Industry |
| Collaborators | Daiichi Sankyo Industry The TIMI Study Group |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Coronary Artery Disease |
| Intervention type | Drug |
| Interventions | Prasugrel, Clopidogrel, Placebo for Prasugrel, Placebo for Clopidogrel |
| Enrollment | 201 |
| Start date | Aug 1, 2006 |
| Primary completion | Jun 1, 2007 |
| Completion | Jun 1, 2007 |
| First posted | Jul 28, 2006 |
| Last update posted | Aug 31, 2010 |
| Countries | France, Germany, Israel, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: